HCPCS Level IIdrugActive
J1747
Inj, spesolimab-sbzo, 1 mg
BETOS: O1E
Effective: 2023-04-01
Referenced in 2 policies
Description
Injection, spesolimab-sbzo, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Spevigo
Manufacturer
Boehringer Ingelheim Pharmaceuticals, Inc.
HCPCS Dosage
1 MG
Billing Units
450.0000
4
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.